Dideoxynucleotide
chain-elongating inhibitors of DNA polymerase

Dideoxynucleotides are chain-elongating inhibitors of DNA polymerase, used in the Sanger method for DNA sequencing. They are also known as 2',3' because both the 2' and 3' positions on the ribose lack hydroxyl groups, and are abbreviated as ddNTPs (ddGTP, ddATP, ddTTP and ddCTP).
Role in the Sanger method
The Sanger method is used to amplify a target segment of DNA, so that the DNA sequence can be determined precisely. The incorporation of ddNTPs in the reaction valves are simply used to terminate the synthesis of a growing DNA strand, resulting in partially replicated DNA fragments. This is because DNA polymerase requires the 3' OH group of the growing chain and the 5' phosphate group of the incoming dNTP to create a phosphodiester bond. Sometimes the DNA polymerase will incorporate a ddNTP and the absence of the 3' OH group will interrupt the condensation reaction between the 5' phosphate (following the cleavage of pyrophosphate) of the incoming nucleotide with the 3' hydroxyl group of the previous nucleotide on the growing strand. This condensation reaction would normally occur with the incorporation of a non-modified dNTP by DNA polymerase. In the simplest of terms, the nucleophilic attack of the 3' OH group leads to the addition of a nucleotide onto a growing chain. The absence of the 3' hydroxyl group inhibits this nucleophilic attack from happening, disabling the DNA polymerase's ability to continue with its function.
This discovery led to its appropriate name "Chain-terminating nucleotides".
The public source identifies “Dideoxynucleotide” as chain-elongating inhibitors of DNA polymerase. This brief keeps that definition visible, then builds a research path around Dideoxynucleotide, chain-elongating and inhibitors.
Why this record matters
A short description can identify a subject without explaining its stakes. For “Dideoxynucleotide”, the useful work is to connect “chain-elongating inhibitors of DNA polymerase” to the records capable of establishing context and consequence.
The citation trail is more important than the brevity of the summary: it shows where individual claims can be examined in context. The source revision retrieved here is dated Jan 27, 2025. The linked authority identifier is Q421201. None of the 0 selected statements returned an explicit reference.
Overview language is designed for orientation and should not be treated as a substitute for the evidence cited beneath it. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Dideoxynucleotide”, its source revision and the description used here.
- Expand the search: follow Dideoxynucleotide primary sources, Dideoxynucleotide archive and Dideoxynucleotide research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Dideoxynucleotide”?
- What terminology or title could unlock a more precise catalogue search?
- Which institution is responsible for the underlying evidence?
Search terms from this dossier
This entry incorporates text from “Dideoxynucleotide” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.